European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“Help shape the future of oligometastatic disease!
ESTRO is establishing a new Focus Group on Oligometastatic Disease, bringing together experts from across disciplines as an international think tank.
As a member, you will have the opportunity to:
- Lead and shape ESTRO webinars, courses, and educational activities
- Initiate impactful science, including manuscripts, position papers, surveys and guidelines
- Collaborate internationally to influence future clinical and research directions.
If you are motivated to actively lead projects and contribute to advancing the field within ESTRO, we warmly invite you to apply!
Apply here.”
More posts about ESTRO.